[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351407-105":59,"doc-detail-351407-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","extending-differential-gene-expression-testing-to-handle-genome-aneuploidy-in-cancer","Extending differential gene expression testing to handle genome aneuploidy in cancer","","Genome aneuploidy, driven by copy number variations (CNVs), reshapes gene expression in cancer through dosage effects and indirect compensatory regulation. Existing differential gene expression (DGE) methods blend these sources, reducing interpretability and masking key tumor progression genes. DeConveil integrates CNV information into a negative binomial generalized linear model, decomposing genes into dosage-sensitive, dosage-insensitive, and dosage-compensated groups. TCGA solid cancer analyses reclassify genes, and functional enrichment assigns distinct roles across tumor progression, immune regulation, and cell adhesion. In a breast cancer study, CNV-aware analysis improves prognostic biomarker discovery and patient risk stratification, outperforming conventional approaches, enabling disentanglement of CNV-driven versus regulatory transcriptional changes for precision oncology.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/extending-differential-gene-expression-testing-to-handle-genome-aneuploidy-in-cancer/351407/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/extending-differential-gene-expression-testing-to-handle-genome-aneuploidy-in-cancer/351407.png","ImageObject",300,407,{"name":92,"@type":93},"Aria Callaghan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does DeConveil address in differential gene expression analysis?","Question",{"text":112,"@type":113},"It addresses how conventional DGE testing conflates direct gene dosage effects from CNVs with indirect compensatory regulatory changes, reducing biological interpretability.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does DeConveil incorporate copy number variations into gene expression modeling?",{"text":117,"@type":113},"It integrates CNV data into a generalized linear model with a negative binomial distribution, modeling RNA-seq counts while accounting for gene dosage effects.",{"name":119,"@type":110,"acceptedAnswer":120},"What gene groups does DeConveil produce and why are they useful?",{"text":121,"@type":113},"It decomposes genes into dosage-sensitive, dosage-insensitive, and dosage-compensated groups to explicitly separate CNV-driven changes from transcriptional regulatory changes, improving interpretation and biomarker discovery.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351407,1790669572,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962084926284,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","OPEN ACCESS  \nCitation: Davydzenka K, Caravagna G, Sanguinetti G (2026) Extending differential gene expression testing to handle genome aneuploidy in cancer. PLoS Comput Biol 22(3):  \ne1014134. [https://doi.org/10.1371/journal](https://doi.org/10.1371/journal). pcbi.1014134  \nEditor: Feilim Mac Gabhann, Johns Hopkins University, UNITED STATES OF AMERICA Received: July 3, 2025  \nAccepted: March 17, 2026  \nPublished: March 27, 2026  \nCopyright: © 2026 Davydzenka et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nData availability statement: All data and code used for running experiments, model fitting, and plotting is available on a GitHub repository at [https://github.com/kdavydzenka/decon](https://github.com/kdavydzenka/decon)veilCaseStudies. We have also used Zenodo to assign a DOI to the repository: [https://doi](https://doi). org/10 .5281/zenodo.15100457. DeConveil is  \nMETHODS  \nExtending differential gene expression testing to handle genome aneuploidy in cancer  \nKatsiaryna Davydzenka1,2, Giulio Caravagna3,4*, Guido Sanguinetti1*  \n1 Theoretical and Scientific Data Science Group, International School of Advanced Studies, Trieste, Italy, 2 University Campus Bio-Medico of Rome, Rome, Italy, 3 Department of Mathematics, Informatics and Geosciences, University of Trieste, Trieste, Italy, 4 Area Science Park, Trieste, Italy  \n* gcaravagna@units. it (GC); [gsanguin@sissa.it](gsanguin@sissa.it) (GS)  \nAbstract  \nGenome aneuploidy, characterized by copy number variations (CNVs), profoundly alters gene expression in cancer through direct gene dosage effects and indirect compensatory regulatory mechanisms. However, existing differential gene expression (DGE) testing methods do not differentiate between these mechanisms, conflatingall expression changes, limiting biological interpretability and obscuring key genes involved in tumor progression. To address this, we developed DeConveil, a computational framework that extends traditional DGE analysis by integrating CNV data. Using a generalized linear model with a negative binomial distribution, DeConveil models RNA-seq expression counts while accounting for copy number gene dosage effects. We proposed a more fine-grained gene decomposition into dosage-sensitive (DSGs), dosage-insensitive (DIGs), and dosage-compensated (DCGs), which explicitly de-couples changes due to CNVs and bona fide changes in transcriptional regulation. Analysis of TCGA datasets from aneuploid solid cancers resulted in notable reclassification of genes, refining and expanding upon the results from conventional methods. Functional enrichment analysis identified distinct biological roles for DSGs, DIGs, and DCGs in tumor progression, immune regulation, and cell adhesion. In abreast cancer case study, DeConveil’s CN-aware analysis facilitated the identification of both known and novel prognostic biomarkers, including lncRNAs, linking gene expression signatures to survival outcomes. Utilizing these biomarkers for each gene group significantly improved patient risk stratification, yielding more accurate predictions compared to conventional methods. These results highlight DeConveil’s ability to disentangle CNV-driven from regulatory transcriptional changes, enhancing gene classification and biomarker discovery. By improving transcriptomic analysis, DeConveil provides a powerful tool for cancer research, precision oncology, with potential applications in therapeutic target identification.  \nPLOS Computational Biology | [https://doi.org/10.1371/journal.pcbi.1014134](https://doi.org/10.1371/journal.pcbi.1014134) March 27, 2026 1 / 23  \navailable as an open-source package written in Python: [https://github.com/caravagnalab/](https://github.com/caravagnalab/)[ ](https://github.com/caravagnalab/)[DeConveil](DeConveil. In parallel)[. ","cbCaie6zweKL9q8g","https://ap.wps.com/l/cbCaie6zweKL9q8g","pdf",2026192,23,"English","# Methods\n## Extending differential gene expression testing to handle genome aneuploidy in cancer","[{\"question\":\"What problem does DeConveil address in differential gene expression analysis?\",\"answer\":\"It addresses how conventional DGE testing conflates direct gene dosage effects from CNVs with indirect compensatory regulatory changes, reducing biological interpretability.\"},{\"question\":\"How does DeConveil incorporate copy number variations into gene expression modeling?\",\"answer\":\"It integrates CNV data into a generalized linear model with a negative binomial distribution, modeling RNA-seq counts while accounting for gene dosage effects.\"},{\"question\":\"What gene groups does DeConveil produce and why are they useful?\",\"answer\":\"It decomposes genes into dosage-sensitive, dosage-insensitive, and dosage-compensated groups to explicitly separate CNV-driven changes from transcriptional regulatory changes, improving interpretation and biomarker discovery.\"}]","Extending differential gene expression testing to handle genome aneuploidy in cancer | PDF",1790094032,58,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/568a431c68add5806285b9b622396cb1.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b5eba5ea9f18b16eb45ed2ef1b3e207a.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8bd62e08c8480a6b47aaa72567354c1d.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7ddcb7d157914340ea5a4c16afa87f2a.webp",980,1268]